Search
Biospace news
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 8 hours 17 min ago
Proxygen Snags Third Big Pharma Partner in Deal Valued at $2.55B
Proxygen Snags Third Big Pharma Partner in Deal Valued at $2.55B 4/5/2023
AstraZeneca’s Imfinzi/Lynparza Combo Boosts Survival in Ovarian Cancer
AstraZeneca’s Imfinzi/Lynparza Combo Boosts Survival in Ovarian Cancer 4/5/2023
FDA Grants EUA to InflaRx’s Anti-Inflammatory COVID-19 Treatment
FDA Grants EUA to InflaRx’s Anti-Inflammatory COVID-19 Treatment 4/5/2023
How to Negotiate a Relocation Package: a Complete Guide
How to Negotiate a Relocation Package: a Complete Guide 4/5/2023
Humira Sales Down 25% as AbbVie Cuts Two Programs
Humira Sales Down 25% as AbbVie Cuts Two Programs 4/28/2023
FDA Greenlights Pfizer’s Pneumococcal Vaccine in Infants and Children
FDA Greenlights Pfizer’s Pneumococcal Vaccine in Infants and Children 4/28/2023
Lilly’s Mounjaro Poised to Challenge Novo’s Wegovy in Obesity
Lilly’s Mounjaro Poised to Challenge Novo’s Wegovy in Obesity 4/28/2023
Beam Spin-Out Orbital Therapeutics Raises $270M to Advance RNA Portfolio
Beam Spin-Out Orbital Therapeutics Raises $270M to Advance RNA Portfolio 4/26/2023
Biogen Bets on Anticipated Approvals Amidst Pipeline Reprioritization
Biogen Bets on Anticipated Approvals Amidst Pipeline Reprioritization 4/26/2023
Novartis Culls 10% of Pipeline, Doubles Down on Five Core Therapeutic Areas
Novartis Culls 10% of Pipeline, Doubles Down on Five Core Therapeutic Areas 4/26/2023
US Senate Kicks Off Fresh Round of Drug Pricing Control Legislation
US Senate Kicks Off Fresh Round of Drug Pricing Control Legislation 4/26/2023
Sponsored: In mRNA Production, You Get Out What You Put In
Sponsored: In mRNA Production, You Get Out What You Put In 4/26/2023
FDA Approves Biogen and Ionis' Qalsody as Fourth-Ever ALS Therapy
FDA Approves Biogen and Ionis' Qalsody as Fourth-Ever ALS Therapy 4/25/2023
Vedanta Raises $106.5M to Advance New Class of C.diff Therapeutics
Vedanta Raises $106.5M to Advance New Class of C.diff Therapeutics 4/25/2023
FDA Presses Pause on Another Foghorn Program
FDA Presses Pause on Another Foghorn Program 4/25/2023
Bluebird Submits BLA for Sickle-Cell Disease Gene Therapy
Bluebird Submits BLA for Sickle-Cell Disease Gene Therapy 4/25/2023
Applied Therapeutics Seeks NDA for Rare Pediatric Disease Drug Despite Phase III Failure
Applied Therapeutics Seeks NDA for Rare Pediatric Disease Drug Despite Phase III Failure 4/25/2023
How to Transition From Academia to Government
How to Transition From Academia to Government 4/25/2023
Ionis and AstraZeneca Seek to Challenge Alnylam with New ATTR Data
Ionis and AstraZeneca Seek to Challenge Alnylam with New ATTR Data 4/24/2023
Supreme Court Maintains Mifepristone Access
Supreme Court Maintains Mifepristone Access 4/24/2023
World Pharma News
- Bayer launches unit to develop new precision health consumer products
- Researchers use ‘natural’ system to identify proteins most useful for developing an effective HIV vaccine
- New blood biomarker can predict if cognitively healthy elderly will develop Alzheimer's disease
- Large study provides scientists with deeper insight into long COVID symptoms
- Pfizer's PAXLOVID™ receives FDA approval for adult patients at high risk of progression to severe COVID-19